Skip to main navigation
  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline + Programs
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
explore the
possibilities

Synlogic Therapeutics

Investor Relations

News & Events

  • Home
  • Synthetic Biology
    • The History of Synthetic Biology
  • Living Medicines
    • Designing Synthetic Biotics
  • Pipeline + Programs
    • Partner with Us
  • Clinical Trials
  • Our People
    • Leadership
    • Board of Directors
    • Founders and Advisors
    • Join Us
  • Investors + Media
    • Company Overview
    • News & Events
      • News Releases
      • Events
      • In the News
    • Presentations & Publications
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Corporate Governance
      • Governance Highlights
      • Management Team
      • Board of Directors
      • Committee Composition
      • Board Diversity Matrix
    • Financials
    • Investor Resources
      • FAQs
      • Contact IR
      • Email Alerts
      • RSS Feeds
News Releases
August 11, 2022
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
August 11, 2022
Synlogic Reports Second Quarter 2022 Financial Results and Provides Business Update
July 28, 2022
Synlogic Announces Second Quarter 2022 Conference Call and Webcast

View All

Upcoming Events

Sep 12 - Sep 14, 2022
The H.C. Wainwright Global Investment Conference
Add to Outlook
Add to Google Calendar
Continue Reading

View All

In the News
Episode 111: Synthetic biology & probiotics, Aoife Brennan, President & CEO, Synlogic
July 20, 2022
Source
Biotech 2050 Podcast
Manufacturing Biotherapeutics Based On Synthetic Biology: Lessons Learned
July 8, 2022
Source
Outsourced Pharma
Managing Manufacturing Requirements for Live Biotherapeutics
June 21, 2022
Source
BioProcess International

View All

  • Email Alerts
  • Contact IR
  • RSS Feeds
  • Print Page
  • Email Page

Synlogic Therapeutics

Contact

Synlogic

301 Binney St #402
Cambridge, MA 02142

info@synlogictx.com
(617) 401-9975

  • Twitter
  • LinkedIn
  • Youtube

Privacy and Terms

© 2022 Synlogic
Privacy Policy